Insight Molecular Diagnostics (IMDX) Net Margin Growth (1y) (2021 - 2026)
Insight Molecular Diagnostics (IMDX) Net Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | -25.00 |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | 454.00 |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 132.00 |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 558.00 |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | -113.00 |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | 112.00 |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | -433.00 |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | 209.00 |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 25.00 |
| 10 | Insight Molecular Diagnostics | 172.94 Mn | 144.01 Mn | 15,000.00 | -3.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.48 Mn |
| Dec 31, 2025 | 23,975.00 |
| Sep 30, 2025 | 755,843.00 |
| Jun 30, 2025 | 252,988.00 |
| Mar 31, 2025 | 499,196.00 |
| Dec 31, 2024 | 197,068.00 |
| Sep 30, 2024 | -1.02 Mn |
| Jun 30, 2024 | -254,362.00 |
| Mar 31, 2024 | -530,563.00 |
| Dec 31, 2023 | -445,357.00 |
| Sep 30, 2023 | 1.28 Mn |
| Jun 30, 2023 | 166,553.00 |
| Mar 31, 2023 | 98,738.00 |
| Dec 31, 2022 | 122,764.00 |
| Sep 30, 2022 | -1.30 Mn |
| Jun 30, 2022 | -301,559.00 |
| Mar 31, 2022 | -63,706.00 |
| Dec 31, 2021 | 31,763.00 |
| Sep 30, 2021 | -18,028.00 |
| Jun 30, 2021 | 432,087.00 |